- Home
- WMK vs CLDX Comparison
WMK vs CLDX Comparison
Compare WMK & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WMK | CLDX |
|---|---|---|
| Founded | 1912 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WMK | CLDX |
|---|---|---|
| Price | $62.25 | $31.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $44.50 |
| AVG Volume (30 Days) | 127.7K | ★ 867.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 5.96 | N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $4,714,573,000.00 | $12,743,000.00 |
| Revenue This Year | N/A | $97.61 |
| Revenue Next Year | N/A | $252.01 |
| P/E Ratio | $24.70 | ★ N/A |
| Revenue Growth | 0.01 | ★ 87.78 |
| 52 Week Low | $61.27 | $14.40 |
| 52 Week High | $90.23 | $31.85 |
Technical Indicators
Market Signals| Indicator | WMK | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 30.22 | 68.43 |
| Support Level | N/A | $24.70 |
| Resistance Level | $68.14 | N/A |
| Average True Range (ATR) | 2.29 | 1.53 |
| MACD | -1.04 | 0.44 |
| Stochastic Oscillator | 6.14 | 93.73 |
Price Performance
Historical ComparisonAbout WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.